Mkts

United Therapeutics Corporation

NASDAQ: UTHR
$577.34-6.76 (-1.16%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
569.34588.43
52-week range
455.63614.23
Today
Open581.43
Previous close577.34
Volume—
Valuation
Market cap23.91B
P/E ratio19.43×
EPS (TTM)26.51
Income & risk
Dividend / yield—
Beta0.46
Avg volume643.5K
Discussion

UTHR News

Stories mentioning UTHR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue781,500790,200799,500798,600794,400735,900748,900714,900
Cost of Goods Sold133,400103,400100,90087,60092,50075,90083,10077,800
Gross Profit648,100686,800698,600711,000701,900660,000665,800637,100
Operating Expenses
Research & Development138,200139,500127,500134,000149,000133,800103,500139,600
Sales General & Admin184,100190,600182,600212,500170,100168,500219,200177,600
Total Operating Expenses
Operating Income (Loss)325,800356,700388,500364,500382,800357,700343,100319,900
Interest Income41,80043,20046,40051,30051,10049,30049,80046,200
Interest Expense
Other Expense(46,300)47,2006,100(100.00)(4,300)(2,600)5,800800.00
Pretax Income318,300444,000438,000408,400423,500396,500388,600355,300
Tax Provision43,40079,70099,30098,900101,30095,20079,50077,200
Net Income (Loss)274,900364,300338,700309,500322,200301,300309,100278,100
Earnings Per Share (Basic)6.328.227.736.867.186.676.936.26
Earnings Per Share (Diluted)5.827.617.166.416.636.216.395.85
Weighted Average Shares Outstanding (Basic)43,50044,30043,80045,10044,90045,20044,60044,400
Weighted Average Shares Outstanding (Diluted)47,20047,90047,30048,30048,60048,50048,40047,500

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About UTHR

United Therapeutics Corporation (NASDAQ: UTHR) is a stock listed on the Nasdaq Stock Market under the ticker symbol UTHR. It last traded at $577.34 (Nov 18, 2026, 4:00 PM ET), down 1.2% on the day. That gives United Therapeutics a market capitalisation of $23.9B and a price-to-earnings ratio of 19.4.

Over the past 52 weeks UTHR has traded between $455.63 and $614.23.

Revenue for the quarter ended Mar 31, 2026 was $781.5M; net income $274.9M. Revenue was down 1.6% from $794.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$781.5M$274.9M35.2%
Dec 31, 2025$790.2M$364.3M46.1%
Sep 30, 2025$799.5M$338.7M42.4%
Jun 30, 2025$798.6M$309.5M38.8%

From United Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…